Package 70518-2402-7

{"route": ["ORAL"], "spl_id": "4a1701b3-b6d9-4b6f-e063-6394a90a5d20", "openfda": {"unii": ["G447S0T1VC"], "rxcui": ["313564"], "spl_set_id": ["7c332401-afb6-455b-b61a-ea108a377ef6"], "manufacturer_name": ["REMEDYREPACK INC."]}, "finished": true, "packaging": [{"sample": false, "description": "21 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (70518-2402-2)", "package_ndc": "70518-2402-2", "marketing_start_date": "20230802"}, {"sample": false, "description": "7 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (70518-2402-7)", "package_ndc": "70518-2402-7", "marketing_start_date": "20250214"}], "brand_name": "Valacyclovir", "product_id": "70518-2402_4a1701b3-b6d9-4b6f-e063-6394a90a5d20", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["DNA Polymerase Inhibitors [MoA]", "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "70518-2402", "generic_name": "Valacyclovir", "labeler_name": "REMEDYREPACK INC.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Valacyclovir", "active_ingredients": [{"name": "VALACYCLOVIR HYDROCHLORIDE", "strength": "1 g/1"}], "application_number": "ANDA203047", "marketing_category": "ANDA", "marketing_start_date": "20191104", "listing_expiration_date": "20271231"}